TC BioPharm Executives to Speak at The 3rd Gamma Delta T Therapies Summit

On July 25, 2022 TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), a clinical stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer treatment, reported that several key executives will speak at The 3rd Gamma Delta T Therapies Summit, which will take place on July 26-28, 2022 in Boston, MA (Press release, TC Biopharm, JUL 25, 2022, View Source [SID1234616915]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

TC BioPharm will participate in five separate conference sessions
Emilio Cosimo, Product Development Manager, will participate in a workshop, "Characterizing Gamma Delta Subsets to Interrogate Function & Therapeutic Application," on July 26, 2022 at 11am EDT.
Dr. Michael Leek, Co-Founder & Executive Chairman, will hold a session, "Gamma Delta T Therapies – From ‘Last Chance’ to Surrogate Front Line Treatment (Vd2)," on July 27, 2022 at 4:30pm EDT.
Angela Scott, Co-Founder & COO, will participate in a panel discussion, "Defining a ‘Super-Donor’ & Discussing Cell Source Considerations to Maximize Off-the-Shelf Product Quality," on July 28, 2022 at 12pm EDT.
Dr. Leek will participate in a panel discussion, "Sharing Perspectives on the Application & Attractiveness of Gamma Delta T Therapy in a Competitive Treatment Landscape," on July 28, 2022 at 12pm EDT.
Scott will hold a session, "Developing Allogeneic Manufacturing Processes to Scale GMP-Compliant, Freeze-Thaw Products (Vd2)," on July 28, 2022 at 2:30pm EDT.
The 3rd Gamma Delta T Therapies Summit will take place in-person for the first time and bring together over 120 leaders in the field. For more information, visit the conference’s website.